National Cancer Institute

BU professor fabricates data in two published experiments

Wednesday, August 10, 2011 11:43 AM

A cancer researcher and assistant professor at the Boston University School of Medicine Cancer Research Center fabricated data in two papers published in scientific journals, federal authorities announced, according to a report by the Boston Globe.

More... »

Genomic launches breast cancer trial

Wednesday, April 27, 2011 02:01 PM

Genomic Health has launched RxPONDER S1007, a breast cancer clinical trial being led by SWOG, one of the National Cancer Institute’s (NCI) cancer cooperative groups.  The trial is designed to determine the effect of chemotherapy in breast cancer patients with one to three positive nodes who have a Recurrence Score (RS) result equal to, or less than, 25 as determined by the Oncotype DX breast cancer test.

More... »

Innovative paperless clinical trial study highlights time and cost savings

Friday, April 15, 2011 11:11 AM

Using interoperable digital identities, digital signatures and cloud computing can accelerate the initiation of a clinical trial and also lower costs, report a group of government and industry cancer researchers. They participated in the phase I of a pilot study that used interoperable digital identities and cloud-based digital signatures to eliminate reliance on paper forms in clinical trials.

More... »

Fred Hutchinson Research Center leads immunotherapy trials

Thursday, April 7, 2011 11:11 AM

The National Cancer Institute has selected 27 sites to participate in a clinical trials network led by the Fred Hutchinson Cancer Research Center to study new cancer drugs, according to the Puget Sound Business Journal.

More... »

Prostate Cancer Foundation Invests in Young Investigators

Monday, May 10, 2010 07:45 AM

The Prostate Cancer Foundation (PCF) boosted its efforts to encourage young investigators to focus on cancer research by awarding $4.5 million in research grants to 21 young investigators at cancer centers in the U.S. and Canada.

More... »

Aptium Oncology Launches Myeloma Research Network as IOM Calls for Improvements in Cancer Research

Wednesday, May 5, 2010 07:26 AM

Aptium Oncology, a consulting and management company for cancer centers, is putting together a network of investigators specifically focused on myeloma and related cancers. The Aptium Oncology Myeloma Consortium (AMyC) is modeled after Aptium’s GI Cancer Consortium, a group launched in 2008 to focus on gastrointestinal cancers.

More... »

CenterWatch Monthly August 2009

Tuesday, August 4, 2009 08:00 AM

Working at the Global Level in China

More... »

CenterWatch Monthly October 2008

Friday, October 3, 2008 02:44 PM

Trio of Companies in Strategic Outsourcing Partnerships with Lilly

More... »

The Right To Use Unproven Treatments?

Tuesday, August 8, 2006 03:11 PM

It’s ironic that at a time when several high-profile marketed drugs have been given a black box warning or withdrawn from the market that the Abigail Alliance has gathered steam.

More... »

Massive Breast Cancer Study Aims for More Informed Treatment Decisons

Thursday, May 25, 2006 02:06 PM

A story in the Chicago Tribune today reports on a new National Cancer Institute (NCI) study planning to enroll over 10,000 women with breast cancer, in order to better understand when the use of chemotherapy is warranted in preventing their tumors from returning after surgery. The study, called TAILORx (Trial Assigning IndividuaLized Options for Treatment Rx) is design to determine whether an individual gene, thought to be associated with the risk of relapse for women with early-stage breast cancer, can be used to aid doctors in choosing treatments with the greatest likelihood of success. The study is sponsored by the National Cancer Institute (NCI), and coordinated by the Eastern Cooperative Oncology Group (ECOG)...

More... »